51. Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance
- Author
-
Katia Devorha Menacho, Sara Ramirez, Aylen Perez, Laura Dragonetti, Diego Perez de Arenaza, Diana Katekaru, Violeta Illatopa, Sara Munive, Bertha Rodriguez, Ana Shimabukuro, Kelly Cupe, Rajiv Bansal, Vivek Bhargava, Ivonne Rodriguez, Andreas Seraphim, Kris Knott, Amna Abdel-Gadir, Salomon Guerrero, Marco Lazo, David Uscamaita, Marco Rivero, Neil Amaya, Sanjiv Sharma, Amelia Peix, Thomas Treibel, Charlotte Manisty, Sam Mohiddin, Harold Litt, Yuchi Han, Juliano Fernandes, Ron Jacob, Mark Westwood, Ntobeko Ntusi, Anna Herrey, John Malcolm Walker, and James Moon
- Subjects
Iron Overload ,Magnetic Resonance Spectroscopy ,Cytidine Monophosphate ,Humans ,Magnetic Resonance Imaging, Cine ,Cardiomyopathies ,Cardiology and Cardiovascular Medicine ,Developing Countries ,Magnetic Resonance Imaging - Abstract
Aims To evaluate the impact of a simplified, rapid cardiovascular magnetic resonance (CMR) protocol embedded in care and supported by a partner education programme on the management of cardiomyopathy (CMP) in low- and middle-income countries (LMICs). Methods and results Rapid CMR focused particularly on CMP was implemented in 11 centres, 7 cities, 5 countries, and 3 continents linked to training courses for local professionals. Patients were followed up for 24 months to assess impact. The rate of subsequent adoption was tracked. Five CMR conferences were delivered (920 attendees—potential referrers, radiographers, reporting cardiologists, or radiologists) and five new centres starting CMR. Six hundred and one patients were scanned. Cardiovascular magnetic resonance indications were 24% non-contrast T2* scans [myocardial iron overload (MIO)] and 72% suspected/known cardiomyopathies (including ischaemic and viability). Ninety-eighty per cent of studies were of diagnostic quality. The average scan time was 22 ± 6 min (contrast) and 12 ± 4 min (non-contrast), a potential cost/throughput reduction of between 30 and 60%. Cardiovascular magnetic resonance findings impacted management in 62%, including a new diagnosis in 22% and MIO detected in 30% of non-contrast scans. Nine centres continued using rapid CMR 2 years later (typically 1–2 days per week, 30 min slots). Conclusions Rapid CMR of diagnostic quality can be delivered using available technology in LMICs. When embedded in care and a training programme, costs are lower, care is improved, and services can be sustained over time.
- Published
- 2022
- Full Text
- View/download PDF